OTHER DLL3 EXPRESSING EPNEC

Clinical trials for OTHER DLL3 EXPRESSING EPNEC explained in plain language.

Never miss a new study

Get alerted when new OTHER DLL3 EXPRESSING EPNEC trials appear

Sign up with your email to follow new studies for OTHER DLL3 EXPRESSING EPNEC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Radioactive 'Magic Bullet' tested against tough cancers

Disease control Recruiting now

This study is testing a new radioactive drug called [212Pb]Pb-DOTAM-MAM279 in adults with advanced small cell lung cancer and other hard-to-treat solid tumors. The main goals are to find a safe and effective dose and to see if the treatment can shrink tumors. The drug is designed…

Matched conditions: OTHER DLL3 EXPRESSING EPNEC

Phase: PHASE1, PHASE2 • Sponsor: Molecular Partners AG • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

OTHER DLL3 EXPRESSING EPNEC

Get alerted when new OTHER DLL3 EXPRESSING EPNEC trials appear

Radioactive 'Magic Bullet' tested against tough cancers